Clinical Trial Update: CB1 Receptor PET Imaging Reveals Gender Differences in PTSD

View source ↗

Summary

This terminated NYU Langone Health clinical trial used CB1 receptor PET imaging to explore potential gender differences in Post-traumatic Stress Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Post-traumatic Stress Disorder (PTSD) | Status: TERMINATED